Clinical Trial Update: Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bendamustine, bortezomib, and rituximab in previously untreated low-grade non-Hodgkin lymphoma has completed, with results posted Decem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Treanda (Bendamustine)
• Velcade (bortezomib)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2015-12-28